1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow BioGrowing Co., Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis Lactobacillus crispatus Lc-G22, Placebo - Vulvovaginal Candidiasis | Not applicable | Completed | BioGrowing Co., Ltd | 100 | 2022-07-01 | 2026-07-27 |
Candidiasis, Vulvovaginal (1) · Recurrence (1)
China (1)